Search - tctmd.com

Displaying 1 - 20 of 89

Sort: Relevancy | Date

News Daily News

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

Caitlin E. Cox

November 21, 2025

Presentation TCT 2025

TCT 65: Colchicine for Post-Myocardial Infarction Management: A Systematic Review and Meta-Analysis

Presenter: Aqeel Khanani

October 28, 2025

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Conference News HFSA 2025

CCM-D Delivers Safe, Effective Integrated Therapy in HFrEF

Yael L. Maxwell

September 29, 2025

Podcast TCTMD Talking Points

The CLEAR SYNERGY (OASIS 9) Trial

September 17, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2025

Caitlin E. Cox

July 31, 2025

News Daily News

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Michael O'Riordan

July 14, 2025

News Daily News

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

Todd Neale

June 06, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Conference News TCT 2024

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Michael O'Riordan

November 06, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2024

Shelley Wood

November 01, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine Versus Placebo and Spironolactone Versus Placebo in Patients With Myocardial Infarction

Presenter: Sanjit Jolly

October 29, 2024

Presentation TCT 2024

TCT 308: Colchicine for the Prevention of Recurrent Non-Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials

Presenter: Michael Sabina

October 29, 2024

Presentation TCT 2024

Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial

Presenter: Thomas Pilgrim

October 29, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News ESC 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Caitlin E. Cox

August 31, 2024

News Daily News

AI-Assisted Look at Coronary Inflammation on CT Refines CV Risk Assessment

Todd Neale

May 31, 2024

Advertisement

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

TCT 65: Colchicine for Post-Myocardial Infarction Management: A Systematic Review and Meta-Analysis

ACC: It’s Time for Clinicians to Address Inflammation in CVD

CCM-D Delivers Safe, Effective Integrated Therapy in HFrEF

The CLEAR SYNERGY (OASIS 9) Trial

TCTMD’s Top 10 Most Popular Stories for July 2025

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

Top Coronary Artery Disease News in 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

TCTMD’s Top 10 Most Popular Stories for October 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine Versus Placebo and Spironolactone Versus Placebo in Patients With Myocardial Infarction

TCT 308: Colchicine for the Prevention of Recurrent Non-Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials

Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial

What’s Going to Be Big at TCT 2024?

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

AI-Assisted Look at Coronary Inflammation on CT Refines CV Risk Assessment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content